142 related articles for article (PubMed ID: 24889928)
1. Knockdown of toll-like receptor 4 inhibits human NSCLC cancer cell growth and inflammatory cytokine secretion in vitro and in vivo.
Li D; Jin Y; Sun Y; Lei J; Liu C
Int J Oncol; 2014 Aug; 45(2):813-21. PubMed ID: 24889928
[TBL] [Abstract][Full Text] [Related]
2. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
[TBL] [Abstract][Full Text] [Related]
3. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
[TBL] [Abstract][Full Text] [Related]
4. Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.
Fu QF; Liu Y; Fan Y; Hua SN; Qu HY; Dong SW; Li RL; Zhao MY; Zhen Y; Yu XL; Chen YY; Luo RC; Li R; Li LB; Deng XJ; Fang WY; Liu Z; Song X
J Hematol Oncol; 2015 Mar; 8():22. PubMed ID: 25887760
[TBL] [Abstract][Full Text] [Related]
5. L1 cell adhesion molecule promotes tumorigenicity and metastatic potential in non-small cell lung cancer.
Hai J; Zhu CQ; Bandarchi B; Wang YH; Navab R; Shepherd FA; Jurisica I; Tsao MS
Clin Cancer Res; 2012 Apr; 18(7):1914-24. PubMed ID: 22307136
[TBL] [Abstract][Full Text] [Related]
6. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.
Hu J; Cheng Y; Li Y; Jin Z; Pan Y; Liu G; Fu S; Zhang Y; Feng K; Feng Y
Eur J Cancer; 2014 Sep; 50(13):2336-50. PubMed ID: 25001183
[TBL] [Abstract][Full Text] [Related]
7. The transmembrane adaptor Cbp/PAG1 controls the malignant potential of human non-small cell lung cancers that have c-src upregulation.
Kanou T; Oneyama C; Kawahara K; Okimura A; Ohta M; Ikeda N; Shintani Y; Okumura M; Okada M
Mol Cancer Res; 2011 Jan; 9(1):103-14. PubMed ID: 21156787
[TBL] [Abstract][Full Text] [Related]
8. NADPH oxidase 1-dependent ROS is crucial for TLR4 signaling to promote tumor metastasis of non-small cell lung cancer.
Liu X; Pei C; Yan S; Liu G; Liu G; Chen W; Cui Y; Liu Y
Tumour Biol; 2015 Mar; 36(3):1493-502. PubMed ID: 25592377
[TBL] [Abstract][Full Text] [Related]
9. FOXP3 and TLR4 protein expression are correlated in non-small cell lung cancer: implications for tumor progression and escape.
Fu HY; Li C; Yang W; Gai XD; Jia T; Lei YM; Li Y
Acta Histochem; 2013 Mar; 115(2):151-7. PubMed ID: 22749378
[TBL] [Abstract][Full Text] [Related]
10. High NUAK1 expression correlates with poor prognosis and involved in NSCLC cells migration and invasion.
Chen P; Li K; Liang Y; Li L; Zhu X
Exp Lung Res; 2013 Feb; 39(1):9-17. PubMed ID: 23215946
[TBL] [Abstract][Full Text] [Related]
11. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
[TBL] [Abstract][Full Text] [Related]
12. RNAi-mediated A disintegrin and metalloproteinase 9 gene silencing inhibits the tumor growth of non-small lung cancer in vitro and in vivo.
Chang L; Gong F; Cui Y
Mol Med Rep; 2015 Jul; 12(1):1197-204. PubMed ID: 25778452
[TBL] [Abstract][Full Text] [Related]
13. Silencing of TLR4 increases tumor progression and lung metastasis in a murine model of breast cancer.
Ahmed A; Wang JH; Redmond HP
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S389-96. PubMed ID: 22890596
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E2 upregulates β1 integrin expression via the E prostanoid 1 receptor/nuclear factor κ-light-chain-enhancer of activated B cells pathway in non-small-cell lung cancer cells.
Bai X; Yang Q; Shu W; Wang J; Zhang L; Ma J; Xia S; Zhang M; Cheng S; Wang Y; Leng J
Mol Med Rep; 2014 May; 9(5):1729-36. PubMed ID: 24584670
[TBL] [Abstract][Full Text] [Related]
15. Human positive coactivator 4 is a potential novel therapeutic target in non-small cell lung cancer.
Peng Y; Yang J; Zhang E; Sun H; Wang Q; Wang T; Su Y; Shi C
Cancer Gene Ther; 2012 Oct; 19(10):690-6. PubMed ID: 22918472
[TBL] [Abstract][Full Text] [Related]
16. The cystic fibrosis transmembrane conductance regulator as a biomarker in non-small cell lung cancer.
Li J; Zhang JT; Jiang X; Shi X; Shen J; Feng F; Chen J; Liu G; He P; Jiang J; Tsang LL; Wang Y; Rosell R; Jiang L; He J; Chan HC
Int J Oncol; 2015 May; 46(5):2107-15. PubMed ID: 25760446
[TBL] [Abstract][Full Text] [Related]
17. Nemo-like kinase (NLK) inhibits the progression of NSCLC via negatively modulating WNT signaling pathway.
Lv L; Wan C; Chen B; Li M; Liu Y; Ni T; Yang Y; Liu Y; Cong X; Mao G; Xue Q
J Cell Biochem; 2014 Jan; 115(1):81-92. PubMed ID: 23904219
[TBL] [Abstract][Full Text] [Related]
18. (-)-Epigallocatechin-3-gallate inhibits human papillomavirus (HPV)-16 oncoprotein-induced angiogenesis in non-small cell lung cancer cells by targeting HIF-1α.
He L; Zhang E; Shi J; Li X; Zhou K; Zhang Q; Le AD; Tang X
Cancer Chemother Pharmacol; 2013 Mar; 71(3):713-25. PubMed ID: 23292117
[TBL] [Abstract][Full Text] [Related]
19. Impact of the integrin signaling adaptor protein NEDD9 on prognosis and metastatic behavior of human lung cancer.
Kondo S; Iwata S; Yamada T; Inoue Y; Ichihara H; Kichikawa Y; Katayose T; Souta-Kuribara A; Yamazaki H; Hosono O; Kawasaki H; Tanaka H; Hayashi Y; Sakamoto M; Kamiya K; Dang NH; Morimoto C
Clin Cancer Res; 2012 Nov; 18(22):6326-38. PubMed ID: 23037767
[TBL] [Abstract][Full Text] [Related]
20. ADAM17 silencing suppresses the migration and invasion of non-small cell lung cancer.
Lv X; Li Y; Qian M; Ma C; Jing H; Wen Z; Qian D
Mol Med Rep; 2014 May; 9(5):1935-40. PubMed ID: 24626788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
